Delivery Order SPE2DX22D0010-SPE2D826FBS20
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $8,026.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of the same day. The contract, which received no set-aside designation, was competitively awarded and represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $37,322.94 to AmerisourceBergen Drug Corp on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The company, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a $13,413.71 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, with completion scheduled for September 9, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,578.88 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $65,330.46 to AmerisourceBergen Drug Corp on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. AmerisourceBergen, headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $12,826.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 12, 2025, with a completion date of November 13, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is for pharmaceutical and medical supply...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order, valued at $42,026.88, represents a non-competitive set-aside award to the prime contractor. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves as a child delivery order under the company's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a $29,898.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 24, 2025, with completion targeted for November 25, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The company, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,370.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The vendor...
- The Defense Logistics Agency awarded a delivery order valued at $6,243.95 to AmerisourceBergen Drug Corp on December 8, 2025, with completion scheduled for December 9, 2025. This contract, issued under firm fixed pricing terms, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order was competitively awarded without set-aside designation and is...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBS20Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $3,362.91 firm fixed price delivery order (Contract No. 4570253343) to AmerisourceBergen Drug Corp on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. AmerisourceBergen Drug Corp maintains an extensive portfolio of pharmaceutical products and medical supplies available through its federal contracts, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company holds a significant $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical running through December 2026, which serves as the overarching vehicle for this delivery order and enables the company to supply pharmaceutical support globally to military healthcare programs, the Defense Health Agency, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 12/10/25 |